PD-L1 regulation revisited: impact on immunotherapeutic strategies.
Sign Up to like & getrecommendations! Published in 2021 at "Trends in molecular medicine"
DOI: 10.1016/j.molmed.2021.06.005
Abstract: A particularly promising cancer treatment is the use of monoclonal antibodies (mAbs) against immune checkpoints (i.e., immune checkpoint inhibitors; ICIs). However, many patients experience relapse and severe adverse events. To overcome these negative issues and… read more here.
Keywords: impact immunotherapeutic; medicine; immunotherapeutic strategies; revisited impact ... See more keywords